Literature DB >> 31804458

Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity.

Rui Guo1, Yinan Hua1, Jun Ren1, Karin E Bornfeldt2, Sreejayan Nair3.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2019        PMID： 31804458      PMCID： PMC6895075          DOI： 10.1038/s41419-019-2113-0

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


Correction to: Cell Death & Disease 10.1038/s41419-018-0727-2 published online 07 June 2018 Since online publication of this article, the authors noticed that there was an error in the TUNEL staining images used to compile Fig. 8a. The error had no impact on the results of the study. The corrected image is provided below. The authors apologise for any inconvenience caused.

Fig. 8

Fig. 8
  2 in total

1.  Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunction.

Authors:  Yinliang Chen; Jinbao Yang; Ying Wang; Weike Shen; Jinlin Liu; Meng Yuan; Xiaoyu Hao; Li Zhong; Rui Guo
Journal:  Front Cardiovasc Med       Date:  2022-03-21

2.  Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis.

Authors:  Xutao Sun; Yunjia Song; Ying Xie; Jieru Han; Fei Chen; Yang Sun; Bowen Sui; Deyou Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-16       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.